3 news items
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
VERV
8 May 24
and development of the Lp(a) program through the completion of Phase 1 clinical development. Lilly will be responsible for subsequent development, manufacturing
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
BMY
IRON
VERV
4 Apr 24
with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy. It is also indicated for the treatment
Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
VERV
2 Apr 24
medical field." In response to this news, Verve's stock price plummeted by over 40% during morning trading on the same day. Please visit
- Prev
- 1
- Next